The Schwab U.S. Dividend Equity ETF Is Near Its All-Time High: Is It Still a Good Buy?

Schwab U.S. Dividend Equity ETF (SCHD) has gained 22% year to date and reached an all-time high, while offering a 3.0% dividend yield versus 1.1% for the S&P 500. Its portfolio traded at an average P/E below 20 at the end of August, compared with 23 for the S&P 500, supporting the view that it remains reasonably valued. However, SCHD has lagged materially over five years, returning 36% versus nearly 80% for the broader index, making it more suited to income-focused investors than those seeking outsized capital appreciation.

Analysis

The relevant signal is not the headline valuation discount but the potential continuation of factor rotation: SCHD is a concentrated quality-value/dividend basket, so incremental flows would disproportionately support mature cash-return franchises rather than the broad “defensive” universe. Its relative multiple discount is partly structural—slower expected earnings growth and sector composition—rather than evidence of a mispricing. The key near-term determinant is therefore real-rate direction: a further decline in long-end yields could compress the valuation gap, while a renewed rise in the 10-year Treasury yield would expose the fund’s duration-sensitive equity holders despite the dividend income.

SCHD’s annual rebalance methodology creates a less-obvious risk: historical dividend growth and cash-flow screens can lag an inflection in cyclicals’ payout capacity. A weakening consumer or industrial cycle would not necessarily affect the ETF evenly; companies that have preserved dividends through buybacks, leverage, or temporarily elevated margins could face sharper multiple compression than the aggregate fund suggests. Conversely, a broad AI-led earnings disappointment would make SCHD a credible relative beneficiary over the next 1-3 months, because its factor exposure offers earnings and valuation diversification from mega-cap growth.

The article provides no independently verifiable evidence of new flows, holdings-level earnings revisions, or a change in distribution sustainability, so it is not a standalone catalyst. NFLX and NVDA have no meaningful read-through: using SCHD enthusiasm as a signal to alter those positions would confuse a defensive/value allocation decision with an AI-growth fundamental view.

Key Decisions for Investors

• No directional trade solely on this article; monitor SCHD relative to SPY and the U.S. 10-year yield for confirmation. A sustained SCHD/SPY breakout alongside falling real yields would support a 1-3 month quality-income rotation thesis.
• If 10-year yields decline by 25-35 bps without a material downgrade to U.S. earnings expectations, consider a tactical long SCHD / short SPY pair for 2-3 months. Target 3-5% relative outperformance; exit if the 10-year yield rises above the pre-entry level by 40 bps or SCHD constituents’ aggregate forward EPS revisions turn negative.
• For portfolios overweight NVDA and other AI beneficiaries, SCHD can serve as a modest factor hedge rather than a return engine: fund the position by trimming broad-market beta, not by shorting NVDA. The hedge fails if AI earnings breadth expands materially or long rates rise, both of which favor growth and pressure dividend-equity relative multiples.
• Before allocating, review SCHD’s current top-10 weight, sector concentration, distribution coverage, and the next rebalance turnover. A payout cut or leverage-driven deterioration at a top holding is more relevant to downside than the ETF-level trailing P/E.